Elevated serum pro-MMP2 levels in patients with advanced lung cancer are not suitable as a prognostic marker

Surgery Today

Volumn 32, Issue 1, 2002, Pages 93-95

  Sasaki, Hidefumi ^a   Kiriyama, Masanobu ^a   Fukai, Ichiro ^a   Yamakawa, Yosuke ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Lung cancer; Metastasis; Pro MMP2

Indexed keywords

BIOLOGICAL MARKER; GELATINASE A;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DISEASE MARKER; ENZYME BLOOD LEVEL; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; PROGNOSIS; THORAX DISEASE;

CASE-CONTROL STUDIES; ENZYME PRECURSORS; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; THORACIC DISEASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0036158731     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s595-002-8124-3     Document Type: Article

References (15)

1. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clows Memorial Award Lecture
2. The pathogenesis of cancer metastasis
3. Matrix metalloproteinases in tumor invasion and metastasis
4. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
5. Type IV collagenases in invasive tumors
6. Tumor invasion and extracellular matrix degradative enzymes: Regulation of activity by organ factors
7. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis
8. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies
9. Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictor of recurrence in patients with orothelial carcinoma
10. Changing view of the role of matrix metalloproteinases in metastasis
11. Tumor cell interactions with the extracellular matrix during invasion and metastasis
12. 92000 Type IV collagenase is increased in plasma of patients with colon cancer and breast cancer
13. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer
14. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension